Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-09-24 to 2024-10-16
Current total value of award: $21164.96
Description: 4565952912!TYSABRI 300 MG/15 ML VIAL 15ML